Director/PDMR Shareholding

Spire Healthcare Group PLC
17 September 2024
 

17 September 2024

 

Spire Healthcare Group plc (the "Company" or "Spire Healthcare")

 

 

Acquisition of Spire Healthcare shares by a Spire Healthcare Director

 

The following Spire Healthcare Director has purchased ordinary shares in the Company as follows:

 

Director

Position

Shares purchased

Date of purchase

Price

Holding post announcement

Justin Ash

Chief Executive Officer

21,100

17 September 2024

236.25 pence

848,740

 

 

Enquiries:

Mantraraj Budhdev

Group General Counsel and Company Secretary

+44 7787 283848

 

Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 

Justin Ash

2

Reason for the notification

a)

Position/status

 

Chief Executive Officer and Executive Director

b)

Initial notification /Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

 

Spire Healthcare Group plc

b)

LEI

213800IBJPW3SE2RA350

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1 pence each

 

GB00BNLPYF73

b)

Nature of the transaction

Purchase of 21,100 ordinary shares at 236.25 pence each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

236.25 pence

21,100

 

d)

Aggregated information

- Aggregated volume

- Price

As above

e)

Date of the transaction

2024-09-17

f)

Place of the transaction

XLON

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings